WallStSmart
ANVS

Annovis Bio Inc

NYSE: ANVS · HEALTHCARE · BIOTECHNOLOGY

$1.98
+7.34% today

Updated 2026-04-30

Market cap
$60.09M
P/E ratio
P/S ratio
EPS (TTM)
$-1.40
Dividend yield
52W range
$1 – $6
Volume
0.8M

Annovis Bio Inc (ANVS) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2009201020112012201720182019202020212022202320242025
Revenue$15717.00$7.17M$0.00$185175.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)+45511.6%-100.0%-100.0%
Cost of revenue$5376.00$6.04M$0.00$11452.00
Gross profit$10341.00$1.13M$0.00$173723.00
Gross margin65.8%15.8%93.8%
R&D$273370.00$111608.00$776256.00$3.05M$8.48M$16.52M$38.79M$20.00M$25.22B
SG&A$359439.00$2.42M$1.95M$1.95M$409063.00$602329.00$829366.00$3.59M$6.06M$9.00M$6.24M$6.70M$4.48B
Operating income$-354890.00$-1.29M$-1.77M$-1.77M$-682433.00$-713937.00$-1.61M$-6.64M$-14.54M$-25.51M$-45.03M$-26.69M$-29.70M
Operating margin-2258.0%-18.0%-958.1%
EBITDA$-682433.00$-713805.00$-791000.00$-5.46M$-14.50M$-25.51M$-45.03M$-26.69M$-29.70M
EBITDA margin0.0%0.0%0.0%
EBIT$-354890.00$-1.29M$0.00$-1.77M$-682433.00$-713937.00$-2.40M$-12.10M$-29.04M$-25.51M$-45.04M
Interest expense$0.00$0.00$0.00$0.00$84.00$66.00$40.93M$47.23M$13335.00$182712.00$1.85M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-369579.00$-1.32M$-4.73M$-8.32M$-682349.00$-713871.00$-991000.00$-5.46M$-14.49M$-25.15M$-56.20M$-24.59M$-28.85M
Net income growth (YoY)-255.9%-259.3%-76.2%+91.8%-4.6%-38.8%-451.2%-165.2%-73.6%-123.5%+56.2%-17.3%
Profit margin-2351.5%-18.3%-4495.6%